AZA
MDT icon

Arthur Zaske & Associates’s Medtronic MDT Stock Holding History

Arthur Zaske & Associates’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$345K Hold
4,270
– – 0.38% 50
2017
Q3 		$332K Hold
4,270
– – 0.35% 46
2017
Q2 		$379K Hold
4,270
– – 0.33% 34
2017
Q1 		$344K Hold
4,270
– – 0.25% 36
2016
Q4 		$304K Hold
4,270
– – 0.22% 49
2016
Q3 		$369K Buy
+4,270
New +$372K 0.55% 35

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Arthur Zaske & Associates's MDT Position: Q4 2017 in Review

Arthur Zaske & Associates held its Medtronic (MDT) position steady in Q4 2017 at 4,270 shares worth $345K. The position accounts for 0.38% of the portfolio, ranked #50.

Arthur Zaske & Associates first reported a position in MDT in Q3 2016 and has held it in 6 quarters since. The position peaked at $379K in Q2 2017. 1,408 funds tracked by Wall St. Rank hold MDT as of Q4 2017.

  • Arthur Zaske & Associates held 4,270 shares of Medtronic worth $345K as of Q4 2017.
  • Arthur Zaske & Associates left its Medtronic share count unchanged in Q4 2017.
  • Medtronic made up 0.38% of Arthur Zaske & Associates's portfolio in Q4 2017, its #50 holding.
  • Arthur Zaske & Associates first reported a position in Medtronic in Q3 2016 and has held it in 6 quarters since.
  • Arthur Zaske & Associates's Medtronic position peaked at $379K in Q2 2017.
  • 1,408 funds tracked by Wall St. Rank held Medtronic as of Q4 2017.

Based on Arthur Zaske & Associates's 13F filing for Q4 2017, filed 14 Feb 2018.